Assignee
EUTROPICS PHARMACEUTICALS INC
US·9 granted patents·12 pending applications·10 citations·filing 2013–2021
Top patents by PatentIndex Score
21 records- 0181US10793915B2Context dependent diagnostics test for guiding cancer treatmentEUTROPICS PHARMACEUTICALS INC·Filed 2016·Granted Oct 6, 2020·5 cites·9 claims
- 0280US9345700B2Compositions and methods useful for treating diseasesEUTROPICS PHARMACEUTICALS INC·Filed 2015·Granted May 24, 2016·2 cites·19 claims
- 0379US9351971B2Substituted 2,2′-biphenazines for treating diseasesEUTROPICS PHARMACEUTICALS INC·Filed 2015·Granted May 31, 2016·3 cites·20 claims
- 0468US10765673B2Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2018·Granted Sep 8, 2020·0 cites·10 claims
- 0566US11656230B2Method for predicting cancer sensitivityEUTROPICS PHARMACEUTICALS INC·Filed 2020·Granted May 23, 2023·0 cites·11 claims
- 0664US2015150869A1Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0764US2018208672A1Antibodies specific to heterodimers of bcl-2 family and uses thereofEUTROPICS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0862US2014234867A1Antibodies Specific to Heterodimers of Bcl-2 Family and Uses ThereofEUTROPICS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0960US11519015B2Methods for determining chemosensitivity and chemotoxicityEUTROPICS PHARMACEUTICALS INC·Filed 2020·Granted Dec 6, 2022·0 cites·19 claims
- 1060US10732182B2Method for predicting cancer sensitivityEUTROPICS PHARMACEUTICALS INC·Filed 2014·Granted Aug 4, 2020·0 cites·9 claims
- 1159US2020392585A1Context dependent diagnostics test for guiding cancer treatmentEUTROPICS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1258US2016178612A1Differential bh3 mitochondrial profilingEUTROPICS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1358US2019257816A1Differential bh3 mitochondrial profilingEUTROPICS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1457US2018246106A1Surrogate functional diagnostics test for cancerEUTROPICS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1555US2015301053A1Surrogate functional diagnostics test for cancerEUTROPICS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1655US2015133450A1Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1753US10640803B2Methods for determining chemosensitivity and chemotoxicityEUTROPICS PHARMACEUTICALS INC·Filed 2014·Granted May 5, 2020·0 cites·14 claims
- 1853US2024043529A1Methods and compositions related to bcl2 and bim heterodimer antibodiesEUTROPICS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1949US10413549B2Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivativesEUTROPICS PHARMACEUTICALS INC·Filed 2017·Granted Sep 17, 2019·0 cites·7 claims
- 2046US2020348280A1Methods for predicting cancer drug responsivenessEUTROPICS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2131US2018100859A1Surrogate functional biomarker for solid tumor cancerEUTROPICS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EUTROPICS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →